Metabolic effects of lisinopril versus hydrochlorothiazide plus amiloride in essential hypertension

[1]  H. Black.  Metabolic considerations in the choice of therapy for the patient with hypertension. , 1991, American heart journal.

[2]  G. Cutter,et al.  The effect of thiazide therapy on glucose, insulin and cholesterol metabolism and of glucose on potassium: results of a cross-sectional study in patients from the Hypertension Detection and Follow-up Program. , 1990, Journal of human hypertension.

[3]  E. Raftery.  The metabolic effects of diuretics and other antihypertensive drugs: a perspective as of 1989. , 1990, International journal of cardiology.

[4]  M. Moser.  Antihypertensive medications: relative effectiveness and adverse reactions , 1990, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[5]  E. Freis.  The cardiotoxicity of thiazide diuretics: review of the evidence , 1990, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[6]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[7]  H. Black.  The Coronary Artery Disease Paradox: The Role of Hyperinsulinemia and Insulin Resistance and Implications for Therapy , 1990, Journal of cardiovascular pharmacology.

[8]  Adesh K. Jain,et al.  Potassium restoration in hypertensive patients made hypokalemic by hydrochlorothiazide. , 1989, Archives of internal medicine.

[9]  C. Berne,et al.  A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. , 1989, The New England journal of medicine.

[10]  W. Sheu,et al.  Effect of prazosin treatment on carbohydrate and lipoprotein metabolism in patients with hypertension. , 1989, The American journal of medicine.

[11]  J. Mehta,et al.  Plasma Lipid Profiles and Antihypertensive Agents: Effects of Lisinopril, Enalapril, Nitrendipine, Hydralazine, and Hydrochlorothiazide , 1988, Drug intelligence & clinical pharmacy.

[12]  C. Lardinois,et al.  The effects of antihypertensive agents on serum lipids and lipoproteins. , 1988, Archives of internal medicine.

[13]  E. Ambrosioni,et al.  Hypolipidemic effects of long-term antihypertensive treatment with captopril. A prospective study. , 1988, The American journal of medicine.

[14]  P. Weidmann,et al.  Effects of Calcium Antagonists on Glucose Homeostasis and Serum Lipids in Non-Diabetic and Diabetic Subjects: A Review , 1987, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[15]  J. Tuomilehto,et al.  Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. , 1987, Journal of hypertension.

[16]  W. Kannel,et al.  Status of risk factors and their consideration in antihypertensive therapy. , 1987, The American journal of cardiology.

[17]  J. Cutler,et al.  The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. , 1986, Progress in cardiovascular diseases.

[18]  N. Borhani,et al.  The relationship between diuretics and serum cholesterol in Hypertension Detection and Follow-up Program participants. , 1986, American journal of preventive medicine.

[19]  J. Huttunen,et al.  Multifactorial primary prevention of cardiovascular diseases in middle-aged men. Risk factor changes, incidence, and mortality. , 1985, JAMA.

[20]  E. Freis,et al.  Early changes in plasma and urinary potassium in diuretic-treated patients with systemic hypertension. , 1984, The American journal of cardiology.

[21]  J. Cutler,et al.  Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial. , 1984, The American journal of medicine.

[22]  R. Ames.  Negative effects of diuretic drugs on metabolic risk factors for coronary heart disease: possible alternative drug therapies. , 1983, The American journal of cardiology.

[23]  D. Andersen,et al.  Prevention of the Glucose Intolerance of Thiazide Diuretics by Maintenance of Body Potassium , 1983, Diabetes.

[24]  J. V. Nixon,et al.  Diuretic-induced ventricular ectopic activity. , 1981, The American journal of medicine.

[25]  C. Bulpitt,et al.  GLUCOSE INTOLERANCE DURING DIURETIC THERAPY Results of Trial by the European Working Party on Hypertension in the Elderly , 1978, The Lancet.

[26]  J. Kassirer,et al.  Diuretics and potassium metabolism: a reassessment of the need, effectiveness and safety of potassium therapy. , 1977, Kidney international.

[27]  C. Dollery,et al.  DETERIORATION OF GLUCOSE TOLERANCE IN HYPERTENSIVE PATIENTS ON PROLONGED DIURETIC TREATMENT , 1976, The Lancet.

[28]  J. N. Morris,et al.  Mortality and hardness of local water-supplies. , 1968, Lancet.

[29]  A. Caggiula,et al.  Diuretic treatment of hypertension and changes in plasma lipids over 6 years in the multiple risk factor intervention trial , 1984 .

[30]  H. Blackburn,et al.  Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial. , 1981, Annals of internal medicine.

[31]  D. Janerich.  Letter: The pill and subsequent pregnancies. , 1975, Lancet.